Natalya A. Polunina

Natalya A. Polunina

Auto-generated profile, based on publicly available information

Natalya A. Polunina

N.V. Sklifosovsky Research Institute for Emergency Medicine, Moscow Healthcare Department; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in World Neurosurgery
Verified
Journal Article
Closed access
VLVictor Lukianchikov
Victor Lukianchikov
ILIvan Lvov
Ivan Lvov
AGAndrey Grin
Andrey Grin
AKAnton Kordonskiy
Anton Kordonskiy
NPNatalia Polunina
Natalia Polunina
VKVladimir Krylov
Vladimir Krylov

1 January 2016 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
VKV. V. Krylov
V. V. Krylov
SESh. Sh. Eliava
Sh. Sh. Eliava
SYS. B. Yakovlev
S. B. Yakovlev
AKA. S. Kheyreddin
A. S. Kheyreddin
OBO. B. Belousova
O. B. Belousova
NPN. A. Polunina
N. A. Polunina

1 January 2017 in Journal of Craniovertebral Junction and Spine
Verified
Journal Article
Open access
PDF file
ILIvan Lvov
Ivan Lvov
VLVictor Lukianchikov
Victor Lukianchikov
AGAndrey Grin
Andrey Grin
ASAleksey Sytnik
Aleksey Sytnik
NPNatalya Polunina
Natalya Polunina
VKVladimir Krylov
Vladimir Krylov
Introduction: Kimmerle anomaly is the bony ridge between the lateral mass of atlas and its posterior arch or transverse process. This bony tunnel may include the V3 segment of the vertebral artery, vertebral vein, posterior branch of the C1 spinal nerve, and the sympathetic nerves, which results in the clinical symptoms of this disease. Reports on the surgical treatment of Kimmerle anomaly are rare. There are no reports on minimally invasive surgical treatment of this pathology. Materials and Methods: Six patients with Kimmerle anomaly were treated from 2015 until 2016. Three patients underwent routine surgery through the posterior midline (posterior midline approach [PMA] group). The other three patients underwent decompression with a paravertebral transmuscular approach (PTMA group). The operation time, intraoperative blood loss, clinical symptoms before and after surgery as well as intra- and post-operative complications were compared between the PTMA and PMA groups. Results: The results of the surgical treatments were assessed at discharge and 1 year later. Blood loss, operation time, and intensity of pain at the postoperative wound area were lower in the PTMA group. There were no postoperative complications. The delayed surgical treatment outcomes did not depend on the method of artery decompression. Conclusions: Surgical treatment of vertebral artery compression in patients with Kimmerle anomaly is preferable in cases where conservative treatment is inefficient. A minimally invasive PTMA is an alternative to the routine midline posterior approach, providing direct visualization of the compressed V3 segment of the vertebral artery and minimizing postoperative pain.

7 March 2022 in Russian neurological Journal
Verified
Journal Article
Closed access
PDF file
LZL. B. Zavaliy
L. B. Zavaliy
GRGanipa Ramazanov
Ganipa Ramazanov
KCK. Ig. Chekhonatskaya
K. Ig. Chekhonatskaya
MSMikhail Sinkin
Mikhail Sinkin
ESE. G. Seliverstova
E. G. Seliverstova
НКН. Ю. Кутровская
Н. Ю. Кутровская
Diagnosis, treatment and rehabilitation of patients with facial neuropathy (FN) is a significant medical problem. The aim of the work was to create, implement and evaluate the effectiveness of an internal algorithm for working with patients suffering from FN.Material and methods. The study included 53 patients: group 1 (n = 27) — treatment in the first 2 weeks from the moment of development of symptoms, group 2 (n = 11) — for more than 2 weeks to 3 months, group 3 (n = 15) — for more than 1 year. The algorithm of diagnosis and treatment were created in the N.V. Sklifosovskii Research Institute of Emergency Medical Care. It includes a multidisciplinary approach, teamwork and continuity.Results. In patients with FN diff erent genesis, at the beginning of treatment in the acute period, complete restoration of the function of the facial nerve and facial muscles occurred in 74% of cases in the period from 2 weeks to 9 months, the period depended on the severity of clinical manifestations (House–Brackmann scale) (r = 0.539, p = 0.014), the degree of nerve damage according to electroneuromyography (ENMG) (r = 0.595, p = 0.006), the severity of complications (contractures and synkinesias) (r = 0.524, p = 0.018). In patients with idiopathic FN, at the beginning of treatment in the acute period, complete recovery was observed in 81.3% of cases. At the beginning of treatment of patients with a disease period of more than a year, conservative tactics led to an improvement in 67% of cases.There was an incomplete correspondence between the clinical (House–Brackmann scale) and degree of nerve damage according to ENMG (r = 0.620, p = 0.004). ENMG should be performed when the House–Brackmann is VI degree. In cases of a decrease in the amplitude of the M-response by 90% or more compared to the healthy side, needle myography (IMG) is indicated. In the absence of motor unit potentials (PDE), it is necessary to consider the issue of surgical treatment, which is indicated in the acute period of FN to every 10 patients, and after a year in cases of lack of recovery — to every second.FN should be considered a progressive disease due to the development of complications, such as the consequences of lagophthalmos, contracture, synkinesia. Lagophthalmos occurs in 73.5% of patients with various consequences — from dry eye syndrome to corneal ulcers, so it is important to use local protective and regenerating drugs early to prevent the development of keratopathies, even with a mild degree of lagophthalmos. Hypertonus of facial muscles is formed already on the 7th day of the disease on the healthy side of the face in an average of 67% of patients, and in the absence of timely treatment — in more than 90% of patients. Synkinesia develops in the period from 4 months to a year in every fifth patient. Timely detection and correction of complications prevents their further development and leads to a complete restoration of the facial nerve function.The success of recovery in FN depends more on identifying the risks of complications and carrying out their prevention. Risk factors for the development of contractures and synkinesias are: prosoplegia, facial nerve damage by more than 90% according to ENMG and gross exercises. FN, despite the different causes of its development, clinically has similar sanogenetic mechanisms, which should be used in rehabilitation.

12 August 2024 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
GAG. P. Arutyunov
G. P. Arutyunov
ODOxana M. Drapkina
Oxana M. Drapkina
ZKZh. D. Kobalava
Zh. D. Kobalava
AKA. O. Konradi
A. O. Konradi
YLYu. M. Lopatin
Yu. M. Lopatin
MFM. Yu. Frolov
M. Yu. Frolov
The paper describes the position of of the Russian Society of Cardiology, the Russian Society for the Prevention of Noncommunicable Diseases, the Russian Scientific Medical Society of Internal Medicine, the Russian Association of Endocrinologists, the Association of Clinical Pharmacologists, the Eurasian Association of Internal Medicine, the Russian Association of Gerontologists and Geriatricians on the most important and controversial issues of the use of fixed-dose combination drugs in the primary and secondary prevention of cardiovascular disease.

24 April 2018 in Russian journal of neurosurgery
Verified
Journal Article
Open access
PDF file
DZD. E. Zakondyrin
D. E. Zakondyrin
NPN. A. Polunina
N. A. Polunina
VLV. A. Luk’yAnchikov
V. A. Luk’yAnchikov
ATA. S. Tokarev
A. S. Tokarev
ISI. V. Sen’kO
I. V. Sen’kO
VKV. V. Krylov
V. V. Krylov
ВНЕДРЕНИЕ РЕЗУЛЬТАТОВ СИМУЛЯЦИОННОГО ОБУЧЕНИЯ В ПРАКТИКУ ОКАЗАНИЯ НЕЙРОХИРУРГИЧЕСКОЙ ПОМОЩИ ПАЦИЕНТАМ СО СТЕНОЗИРУЮЩИМИ ПОРАЖЕНИЯМИ СОННЫХ АРТЕРИЙ